NAV as on 13-06-2025
AUM as on
Rtn ( Since Inception )
35.44%
Inception Date
Oct 04, 2023
Expense Ratio
2.02%
Fund Status
Open Ended Schemes
Min. Investment
100
Min. Topup
100
Min. SIP Amount
100
Risk Status
very high
Investment Objective : To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.